Refining the treatment of NSCLC according to histological and molecular subtypes

The response of various types of bronchogenic carcinoma to nitrogen mustard. Annals of Internal Medicine. ,vol. 42, pp. 1089- 1096 ,(1955) , 10.7326/0003-4819-42-5-1089

Adam S Crystal, Alice T Shaw, Lecia V Sequist, Luc Friboulet, Matthew J Niederst, Elizabeth L Lockerman, Rosa L Frias, Justin F Gainor, Arnaud Amzallag, Patricia Greninger, Dana Lee, Anuj Kalsy, Maria Gomez-Caraballo, Leila Elamine, Emily Howe, Wooyoung Hur, Eugene Lifshits, Hayley E Robinson, Ryohei Katayama, Anthony C Faber, Mark M Awad, Sridhar Ramaswamy, Mari Mino-Kenudson, A John Iafrate, Cyril H Benes, Jeffrey A Engelman, None, Patient-derived models of acquired resistance can identify effective drug combinations for cancer Science. ,vol. 346, pp. 1480- 1486 ,(2014) , 10.1126/SCIENCE.1254721

Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin J. Solomon, Juergen Wolf, Michael Thomas, Martin Schuler, Geoffrey Liu, Armando Santoro, Yvonne Y. Lau, Meredith Goldwasser, Anthony L. Boral, Jeffrey A. Engelman, Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 370, pp. 1189- 1197 ,(2014) , 10.1056/NEJMOA1311107

Jean-Louis Pujol, Robert Pirker, Thomas J. Lynch, Charles A. Butts, Rafael Rosell, Frances A. Shepherd, Johan Vansteenkiste, Kenneth J. O’Byrne, Barbara de Blas, Jim Heighway, Anja von Heydebreck, Nick Thatcher, Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer Lung Cancer. ,vol. 83, pp. 211- 218 ,(2014) , 10.1016/J.LUNGCAN.2013.11.006

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F

Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516

Robert A. Green, Edward Humphrey, Henry Close, Mary Ellen Patno, Alkylating agents in bronchogenic carcinoma The American Journal of Medicine. ,vol. 46, pp. 516- 525 ,(1969) , 10.1016/0002-9343(69)90071-0

G. Iyer, A. J. Hanrahan, M. I. Milowsky, H. Al-Ahmadie, S. N. Scott, M. Janakiraman, M. Pirun, C. Sander, N. D. Socci, I. Ostrovnaya, A. Viale, A. Heguy, L. Peng, T. A. Chan, B. Bochner, D. F. Bajorin, M. F. Berger, B. S. Taylor, D. B. Solit, Genome Sequencing Identifies a Basis for Everolimus Sensitivity Science. ,vol. 338, pp. 221- 221 ,(2012) , 10.1126/SCIENCE.1226344

D. Ross Camidge, William Pao, Lecia V. Sequist, Acquired resistance to TKIs in solid tumours: learning from lung cancer Nature Reviews Clinical Oncology. ,vol. 11, pp. 473- 481 ,(2014) , 10.1038/NRCLINONC.2014.104

Alice T. Shaw, Sai-Hong I. Ou, Yung-Jue Bang, D. Ross Camidge, Benjamin J. Solomon, Ravi Salgia, Gregory J. Riely, Marileila Varella-Garcia, Geoffrey I. Shapiro, Daniel B. Costa, Robert C. Doebele, Long Phi Le, Zongli Zheng, Weiwei Tan, Patricia Stephenson, S. Martin Shreeve, Lesley M. Tye, James G. Christensen, Keith D. Wilner, Jeffrey W. Clark, A. John Iafrate, Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 371, pp. 1963- 1971 ,(2014) , 10.1056/NEJMOA1406766